Minimal effective dose of mefloquine/sulfadoxine/pyrimethamine in mild Plasmodium falciparum malaria.
Radloff
P D
PD
Philipps
J
J
Nkeyi
M
M
Handschin
J
J
Stürchler
D
D
Kremsner
P G
PG
D000293:Adolescent; D000962:Antimalarials / Q000627:therapeutic use*; D002648:Child; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D016778:Malaria, Falciparum / Q000188:drug therapy*; D008297:Male; D015767:Mefloquine / Q000008:administration & dosage*; D010865:Pilot Projects; D011739:Pyrimethamine / Q000008:administration & dosage*; D013413:Sulfadoxine / Q000008:administration & dosage*
D000962:Antimalarials; D013413:Sulfadoxine; D015767:Mefloquine; D011739:Pyrimethamine